Kohli R, Ratziu V, Fiel MI, Waldmann E, Wilson DP, Balwani M. Initial assessment and ongoing monitoring of lysosomal acid lipase deficiency in children and adults: Consensus recommendations from an international collaborative working group. Mol Genet Metab. 2020;129(2):59–66. https://doi.org/10.1016/j.ymgme.2019.11.004.
Article CAS PubMed Google Scholar
Pericleous M, Kelly C, Wang T, Livingstone C, Ala A. Wolman’s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol. 2017;2(9):670–9. https://doi.org/10.1016/S2468-1253(17)30052-3.3.
Li F, Zhang H. Lysosomal acid lipase in lipid metabolism and Beyond. Arterioscler Thromb Vasc Biol. 2019;39(5):850–6. https://doi.org/10.1161/ATVBAHA.119.312136.
Article CAS PubMed PubMed Central Google Scholar
Zhang H. Lysosomal acid lipase and lipid metabolism: new mechanisms, new questions, and new therapies. Curr Opin Lipidol. 2018;29(3):218–23. https://doi.org/10.1097/MOL.0000000000000507.
Article CAS PubMed PubMed Central Google Scholar
Carter A, Brackley SM, Gao J, Mann JP. The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: a rare condition that mimics NAFLD. J Hepatol. 2019;70(1):142–50. https://doi.org/10.1016/j.jhep.2018.09.028.
Article CAS PubMed Google Scholar
Consuelo-Sanchez A, Vázquez-Frías R, Reyes-de la Rosa A, Acosta-Rodríguez-Bueno CP, Ortal-Vite MP, Cebolla JJ. Mutations identified in a cohort of Mexican patients with lysosomal acid lipase deficiency. Ann Hepatol. 2019;18(4):646–50. https://doi.org/10.1016/j.aohep.2018.07.005.
Article CAS PubMed Google Scholar
Camarena C, Aldamiz-Echevarria LJ, Polo B, Barba Romero MA, García I, Cebolla JJ, Ros E. Update on lysosomal acid lipase deficiency: diagnosis, treatment and patient management. Med Clin (Barc). 2017;148(9):429. .e1-429.e10.
Fulcher AS, Das Narla L, Hingsbergen EA. Pediatric case of the day. Wolman disease (primary familial xanthomatosis with involvement and clacification of the adrenal glands). Radiographics. 1998;18(2):533–5. https://doi.org/10.1148/radiographics.18.2.9536498.
Article CAS PubMed Google Scholar
Baronio F, Conti F, Miniaci A, Carfagnini F, Di Natale V, Di Donato G, Testi M, Totaro C, De Fanti A, Boenzi S, Dionisi-Vici C, Esposito S, Pession A. Diagnosis, treatment, and follow-up of a case of Wolman disease with hemophagocytic lymphohistiocytosis. Mol Genet Metab Rep. 2021;30:100833. https://doi.org/10.1016/j.ymgmr.2021.100833.
Article CAS PubMed PubMed Central Google Scholar
Bartakke S, Nisal A, Bafna V, Valecha A. Secondary Hemophagocytic Lymphohistiocytosis in an infant with Wolman Disease. Indian J Hematol Blood Transfus. 2021;37(1):191–2. https://doi.org/10.1007/s12288-020-01350-4.
Tinsa F, Ben Romdhane M, Boudabous H, Bel Hadj I, Brini I, Tebib N, Louati H, Bekri S, Boussetta K. A Novel Mutation c.153 C > A in a Tunisian girl with Wolman Disease and unusual presentation: Hemophagocytic Lymphohistiocytosis. J Pediatr Hematol Oncol. 2019;41(3):e193–6. https://doi.org/10.1097/MPH.0000000000001192.
Article CAS PubMed Google Scholar
Jones SA, Valayannopoulos V, Schneider E, Eckert S, Banikazemi M, Bialer M, Cederbaum S, Chan A, Dhawan A, Di Rocco M, Domm J, Enns GM, Finegold D, Gargus JJ, Guardamagna O, Hendriksz C, Mahmoud IG, Raiman J, Selim LA, Whitley CB, Zaki O, Quinn AG. Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants. Genet Med. 2016;18(5):452–8. https://doi.org/10.1038/gim.2015.108.
Hamilton J, Jones I, Srivastava R, Galloway P. A new method for the measurement of lysosomal acid lipase in dried blood spots using the inhibitor lalistat 2. Clin Chim Acta. 2012;413(15–16):1207–10. https://doi.org/10.1016/j.cca.2012.03.019.
Article CAS PubMed Google Scholar
Del Angel G, Hutchinson AT, Jain NK, Forbes CD, Reynders J. Large-scale functional LIPA variant characterization to improve birth prevalence estimates of lysosomal acid lipase deficiency. Hum Mutat. 2019;40(11):2007–20. https://doi.org/10.1002/humu.23837.
Article CAS PubMed PubMed Central Google Scholar
Demaret T, Lacaille F, Wicker C, Arnoux JB, Bouchereau J, Belloche C, Gitiaux C, Grevent D, Broissand C, Adjaoud D, Abi Warde MT, Plantaz D, Bekri S, de Lonlay P, Brassier A. Sebelipase alfa enzyme replacement therapy in Wolman disease: a nationwide cohort with up to ten years of follow-up. Orphanet J Rare Dis. 2021;16(1):507. https://doi.org/10.1186/s13023-021-02134-3.
Article PubMed PubMed Central Google Scholar
Burton BK, Feillet F, Furuya KN, Marulkar S, Balwani M. Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: final results of the ARISE study. J Hepatol. 2022;76:577–87. https://doi.org/10.1016/j.jhep.2021.10.026.
Article CAS PubMed Google Scholar
Balwani M, Breen C, Enns GM, Deegan PB, Honzík T, Jones S, Kane JP, Malinova V, Sharma R, Stock EO, Valayannopoulos V, Wraith JE, Burg J, Eckert S, Schneider E, Quinn AG. Clinical effect and safety profile of recombinant human lysosomal acid lipase in patients with cholesteryl ester storage disease. Hepatology. 2013;58(3):950–7. https://doi.org/10.1002/hep.26289.
Article CAS PubMed Google Scholar
Burton BK, Sanchez AC, Kostyleva M, Martins AM, Marulkar S, Abel F, Barić I. Long-term sebelipase Alfa Treatment in children and adults with lysosomal Acid Lipase Deficiency. J Pediatr Gastroenterol Nutr. 2022;74(6):757–64. https://doi.org/10.1097/MPG.0000000000003452.
Jones SA, Rojas-Caro S, Quinn AG, Friedman M, Marulkar S, Ezgu F, Zaki O, Gargus JJ, Hughes J, Plantaz D, Vara R, Eckert S, Arnoux JB, Brassier A, Le Quan Sang KH, Valayannopoulos V. Survival in infants treated with sebelipase Alfa for lysosomal acid lipase deficiency: an open-label, multicenter, dose-escalation study. Orphanet J Rare Dis. 2017;12(1):25. https://doi.org/10.1186/s13023-017-0587-3.
Article PubMed PubMed Central Google Scholar
Vijay S, Brassier A, Ghosh A, Fecarotta S, Abel F, Marulkar S, Jones SA. Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies. Orphanet J Rare Dis. 2021;16(1):13. https://doi.org/10.1186/s13023-020-01577-4. Erratum in: Orphanet J Rare Dis. 2021;16(1):113. PMID: 33407676; PMCID: PMC7789691.
Guy GJ, Butterworth J. Acid esterase activity in cultured skin fibroblasts and amniotic fluid cells using 4-methylumbelliferyl palmitate. Clin Chim Acta. 1978;84(3):361–71. https://doi.org/10.1016/0009-8981(78)90253-x.
Article CAS PubMed Google Scholar
Lukacs Z, Barr M, Hamilton J. Best practice in the measurement and interpretation of lysosomal acid lipase in dried blood spots using the inhibitor lalistat 2. Clin Chim Acta. 2017;471:201–5. https://doi.org/10.1016/j.cca.2017.05.027. Epub 2017 May 19. PMID: 28532785.
Article CAS PubMed Google Scholar
Lin N, Zhang H, Qiu W, Ye J, Han L, Wang Y, Gu X. Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-pick disease. J Lipid Res. 2014;55(2):338–43. https://doi.org/10.1194/jlr.D044024.
Article CAS PubMed PubMed Central Google Scholar
Narayanaswamy R, Iyer V, Khare P, Bodziak ML, Badgett D, Zivadinov R, Weinstock-Guttman B, Rideout TC, Ramanathan M, Browne RW. Simultaneous determination of oxysterols, cholesterol and 25-hydroxy-vitamin D3 in human plasma by LC-UV-MS. PLoS ONE. 2015;10(4):e0123771. https://doi.org/10.1371/journal.pone.0123771.
Article CAS PubMed PubMed Central Google Scholar
Cooper JA, Church HJ, Wu HY, Cholestane-3β. 5α, 6β-triol: further insights into the performance of this oxysterol in diagnosis of Niemann-pick disease type C. Mol Genet Metab. 2020;130(1):77–86. https://doi.org/10.1016/j.ymgme.2020.02.008.
Article CAS PubMed Google Scholar
Ruiz-Andrés C, Sellés E, Arias A, Gort L, Spanish LAL, Deficiency Working Group. Lysosomal Acid Lipase Deficiency in 23 Spanish patients: high frequency of the Novel c.966 + 2T > G mutation in Wolman Disease. JIMD Rep. 2017;37:7–12. https://doi.org/10.1007/8904_2017_6.
Article PubMed PubMed Central Google Scholar
Potter JE, Petts G, Ghosh A, White FJ, Kinsella JL, Hughes S, Roberts J, Hodgkinson A, Brammeier K, Church H, Merrigan C, Hughes J, Evans P, Campbell H, Bonney D, Newman WG, Bigger BW, Broomfield A, Jones SA, Wynn RF. Enzyme replacement therapy and hem
留言 (0)